Berman Capital Advisors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$15,000
-6.2%
5660.0%0.00%
-33.3%
Q2 2021$16,000
+6.7%
566
+3.1%
0.00%0.0%
Q1 2021$15,0000.0%549
-2.5%
0.00%
-25.0%
Q4 2020$15,000
+7.1%
5630.0%0.00%0.0%
Q3 2020$14,000
+7.7%
5630.0%0.00%
+33.3%
Q2 2020$13,000
+116.7%
563
+19.5%
0.00%
+50.0%
Q1 2020$6,000
-14.3%
4710.0%0.00%0.0%
Q4 2019$7,000
+16.7%
4710.0%0.00%0.0%
Q3 2019$6,0004710.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders